Search
Products
Community
Markets
News
Brokers
More
EN
Get started
Community
/
Ideas
/
auph FDA approval retrace
Aurinia Pharmaceuticals Inc
Long
auph FDA approval retrace
By des
Follow
Follow
Feb 12, 2021
0
Feb 12, 2021
Spike from FDA approval. Anticipate pull back to 61 fib level. MT - price target is 61 feb extension level.
Chart Patterns
des
Follow
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the
Terms of Use
.